deltatrials
Terminated NA INTERVENTIONAL 2-arm NCT01598025

Biparental HLA Haplotype Disparate T-cell Depleted Transplants for Patients Lacking an HLACompatible Donor

Sponsor: Memorial Sloan Kettering Cancer Center

Conditions Acute Leukemia Chronic Leukemia Myelodysplastic Syndrome Non-Hodgkins Lymphoma
Interventions allogeneic hematopoietic stem cell transplantation anti-thymocyte globulin fludarabine phosphate laboratory biomarker analysis melphalan peripheral blood stem cell transplantation thiotepa total-body irradiation (TBI)
Updated 11 times since 2017 Last updated: Jul 12, 2018 Started: May 2, 2012 Primary completion: Oct 16, 2017 Completion: Oct 16, 2017
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Closed due to poor accrual

Other terminated trials from Memorial Sloan Kettering Cancer Center

See all terminations from Memorial Sloan Kettering Cancer Center

Other Acute Leukemia trials with similar outcome

Browse all Acute Leukemia trials

This NA trial investigates Acute Leukemia and Chronic Leukemia and is currently terminated or withdrawn. Memorial Sloan Kettering Cancer Center leads this study, which shows 11 recorded versions since 2012 — indicating substantial longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshotActive Not Recruiting~Feb 2017 – ~Jun 2017 · 4 months · monthly snapshotActive Not Recruiting~Jun 2017 – ~May 2018 · 11 months · monthly snapshotActive Not Recruiting~May 2018 – ~Jun 2018 · 31 days · monthly snapshotTerminated~Jun 2018 – ~Sep 2018 · 3 months · monthly snapshotTerminated~Sep 2018 – ~Jan 2021 · 28 months · monthly snapshotTerminated~Jan 2021 – ~Dec 2022 · 23 months · monthly snapshotTerminated~Dec 2022 – ~Jan 2023 · 31 days · monthly snapshotTerminated~Jan 2023 – ~Jul 2024 · 18 months · monthly snapshotTerminated~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotTerminated~Sep 2024 – present · 22 months · monthly snapshotTerminated

Change History

11 versions recorded

  1. Sep 2024 — Present [monthly]

    Terminated NA

  2. Jul 2024 — Sep 2024 [monthly]

    Terminated NA

  3. Jan 2023 — Jul 2024 [monthly]

    Terminated NA

  4. Dec 2022 — Jan 2023 [monthly]

    Terminated NA

  5. Jan 2021 — Dec 2022 [monthly]

    Terminated NA

▶ Show 6 earlier versions

  1. Sep 2018 — Jan 2021 [monthly]

    Terminated NA

  2. Jun 2018 — Sep 2018 [monthly]

    Terminated NA

  3. May 2018 — Jun 2018 [monthly]

    Terminated NA

    Status: Active Not Recruiting → Terminated

  4. Jun 2017 — May 2018 [monthly]

    Active Not Recruiting NA

  5. Feb 2017 — Jun 2017 [monthly]

    Active Not Recruiting NA

  6. Jan 2017 — Feb 2017 [monthly]

    Active Not Recruiting NA

    First recorded

May 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Memorial Sloan Kettering Cancer Center
Data source: Memorial Sloan Kettering Cancer Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations